News

Multiple Research Results of CSPC Unveiled at ASH Annual Meeting

January 11, 2024

The 65th American Society of Hematology (ASH) Annual Meeting was held on December 9-12, 2023 in San Diego, USA. As an international authoritative academic hematology event, the conference presented the latest global hematology research results and explored the choice for clinical benefits of new treatment options.

The relevant latest clinical research results of Duoenda® (Mitoxantrone Hydrochloride Liposome Injection) and Duomeisu® (Doxorubicin Hydrochloride Liposome Injection), star products of CSPC, were unveiled at the meeting. We hereby summarize and present them.

 


Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat